Use access key #2 to skip to page content.
  • S&P 500: 1,106.65
  • Change: 0.61%
$2.82 -0.15 (-5.05%)
12/4/2009 12:15 PM

Keryx Biopharmaceuticals (KERX)

CAPS Rating:
***

A biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating KERX

Add Stock to Watchlist

What the Community Thinks

Total Members

155 Outperforms
11 Underperforms
 

All-Stars

38 Outperforms
6 Underperforms
 

Wall Street

2 Outperforms
1 Underperforms
 

Members bullish on KERX are also bullish on:

Members bearish on KERX are also bearish on:

Ticker Tags

Biotechnology (225), Healthcare (732), Defensive (1498), Rule Breakers Universe (128), Micro Cap (4789), Growth (1900)
Suggest a tag

Keryx Biopharmaceuticals At A Glance

Current Price: $2.82
Last Trade Time: 12/4/2009 12:15 PM
Open: $3.00
Previous Close: $2.97
Daily Range: $2.80 - $3.00
52-Week Range: $0.09 - $3.33
Volume: 1,615,953
Market Cap: $157.87M
P/E Ratio: 11.42
Compare Our Special Broker Offers!

Stock Trends

KERX VS S&P 500 (SPY)

News & Discussion Boards

Top Bull Pitch

Recs

1

Keryx Biopharmaceuticals (KERX)

Avatar Timbofittz88 (< 20) Submitted: 12/01/09 11:33 AM

good job guys

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1

Keryx Biopharmaceuticals (KERX)

Avatar supez2004 (78.70) Submitted: 3/03/08 1:13 AM

Phase 3 for sulodexide unlikely to impress ...

Replies: 1 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 26 :   1 2 3 4 5 Next »

Show Pitch Replies

Recs

1

 (KERX)

Avatar Timbofittz88 (< 20) Submitted: 12/01/09 11:33 AM : Outperform Start Price: $2.70 KERX Score: 7.21

good job guys

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (KERX)

Avatar VietSpeed (41.70) Submitted: 11/19/09 3:16 AM : Outperform Start Price: $2.36 KERX Score: 21.00

The future.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (KERX)

Avatar jackbot (52.24) Submitted: 11/18/09 3:04 PM : Outperform Start Price: $2.25 KERX Score: 23.97

This spry little biotech has a great balance sheet for such a small, experimental company.

Report this Post Replies: 1 | Reply | Permalink

Recs

0

 (KERX)

Avatar waysane (< 20) Submitted: 11/10/09 1:36 PM : Outperform Start Price: $2.14 KERX Score: 32.99

Big Pharm always makes money

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (KERX)

Avatar harlanror (< 20) Submitted: 11/09/09 4:05 PM : Outperform Start Price: $2.29 KERX Score: 24.42

this company has some strong drugs in the pipeline, should hit on many of them. stock could double or triple.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 26 :   1 2 3 4 5 Next »

Wall Street

Results 1 - 3 of 3  

picks per page. CHANGE

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackBearStearns 86.67 09/17/09 Underperform NS $1.88+52.66%+4.45%-48.20
TrackBreanMurray 87.10 09/16/09 Outperform NS $1.88+52.66%+4.45%+48.20
TrackPZK < 20 09/16/09 Outperform NS $1.88+52.66%+4.45%+48.20

Results 1 - 3 of 3  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD03 500ms